Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
aTYR PHARMA INC (LIFE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2023 |
4
| Zaknoen Sara (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 12,000 options to buy
@ $2.52, valued at
$30.2k
|
|
| 05/19/2023 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 12,000 options to buy
@ $2.52, valued at
$30.2k
|
|
| 05/19/2023 |
4
| Lucas Svetlana (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 12,000 options to buy
@ $2.52, valued at
$30.2k
|
|
| 05/19/2023 |
4
| Gross Jane A (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 12,000 options to buy
@ $2.52, valued at
$30.2k
|
|
| 05/19/2023 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Gifted 6,000 shares
@ $0
Gifted 6,000 shares
@ $0
Granted 12,000 options to buy
@ $2.52, valued at
$30.2k
|
|
| 05/19/2023 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 12,000 options to buy
@ $2.52, valued at
$30.2k
|
|
| 05/11/2023 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 200,000 shares
@ $2.25, valued at
$450k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Exercised 6,000 restricted stock units
@ $0 |
|
| 04/28/2023 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Exercised 6,000 restricted stock units
@ $0 |
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2023 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 336,096 options to buy
@ $2.195, valued at
$737.7k
|
|
| 02/21/2023 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 84,023 options to buy
@ $2.195, valued at
$184.4k
|
|
| 02/21/2023 |
4
| DENYES NANCY (General Counsel) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 84,023 options to buy
@ $2.195, valued at
$184.4k
|
|
| 02/06/2023 |
4
| DENYES NANCY (General Counsel) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Exercised 2,688 restricted stock units
@ $0 |
|
| 02/06/2023 |
4
| Broadfoot Jill Marie (CFO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Sold 1,566 shares
@ $2.36, valued at
$3.7k
Exercised 3,750 restricted stock units
@ $0 |
|
| 02/06/2023 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Exercised 10,375 restricted stock units
@ $0 |
|
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Bought 15,000 shares
@ $2.8776, valued at
$43.2k
|
|
| 05/26/2022 |
4
| DENYES NANCY (General Counsel) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 88,097 options to buy
@ $2.81, valued at
$247.6k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 516,280 options to buy
@ $2.81, valued at
$1.5M
|
|
| 04/28/2022 |
4
| Zaknoen Sara (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 04/28/2022 |
4
| SCHIMMEL PAUL (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 04/28/2022 |
4
| Lucas Svetlana (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 04/28/2022 |
4
| Gross Jane A (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 04/28/2022 |
4
| COUGHLIN TIMOTHY (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 04/28/2022 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 02/07/2022 |
4
| DENYES NANCY (General Counsel) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 21,500 options to buy
@ $5.52, valued at
$118.7k
Granted 10,750 restricted stock units
@ $0 |
|
| 02/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2022 |
4
| Shukla Sanjay (President and CEO) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 83,000 options to buy
@ $5.52, valued at
$458.2k
Granted 41,500 restricted stock units
@ $0 |
|
|
|
|